Repetitive Thoughts in Fibromyalgia: Impact of Rumination on the Emotional and Cognitive Dimensions of Fibromyalgia

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

107 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-09-16

Study Completion Date

2017-11-26

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Dysfunctional chronic diffuse pain syndrome, concerning 2% of the French population, Fibromyalgia (FM) is classified either as a psychological disease or as a somatic disease. This dichotomous reasoning does not lead to a better understanding and does not allow the use or development of new psychological tools of care.

The issue of the proximity between FM and depression highlighted by some authors and the presence of anxious comorbidities may arise at a different level, that of the transdiagnostic approach. Rumination is one of these transdiagnostic processes that are the subject of recent studies and one of the dimensions of which (abstract analytical rumination) is at work in depression and a number of psychopathologies. The investigator therefore wishes to explore the process of rumination and its abstract analytical dimension in FM and to explore its link with the depressive and anxious manifestations frequently associated with this disorder.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Repetitive Thinking in Fibromyalgia

NCT03964285

Rumination Fibromyalgia Chronic Pain +1 more

COMPLETED NA

Assessment of Psychological Symptoms Among Fibromyalgia Patients

NCT05557500

Psychological Symptoms in Fibromyalgia Patients

UNKNOWN NA

Multicomponent Therapy for Fibromyalgia

NCT03319355

Fibromyalgia

COMPLETED NA

Repetitive Thinking in FibroMyalgia and Attentional Bias

NCT03466892

Chronic Pain

COMPLETED

Neuroimaging Effects of Cognitive Behavioral Therapy in Fibromyalgia

NCT01345344

Fibromyalgia

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Fibromyalgia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patient with Fibromyalgia

Group Type OTHER

Evaluate the link between an abstract / analytical thinking style and depressive manifestations in FM.

Intervention Type OTHER

Evaluate the link between an abstract / analytical thinking style and depressive manifestations in FM.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Evaluate the link between an abstract / analytical thinking style and depressive manifestations in FM.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* FM Criteria of the American College of Rheumatology ACR 1990.
* Major Patients
* free and informed consent signed
* stable treatment for at least one month
* Native French speaker
* Patient covered by health insurance.